3-aminobenzamide has been researched along with 3-nitrotyrosine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (29.41) | 18.2507 |
| 2000's | 11 (64.71) | 29.6817 |
| 2010's | 1 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuzzocrea, S; Salzman, AL; Szabó, C; Zingarelli, B; Zsengellér, Z | 1 |
| Caputi, AP; Cuzzocrea, S; Zingarelli, B | 1 |
| Cuzzocrea, S; Marmer, D; Salzman, AL; Scott, GS; Szabó, C; Virág, L | 1 |
| Caputi, AP; Costantino, G; Cuzzocrea, S; Zingarelli, B | 1 |
| Cotton, RT; Salzman, A; Stern, Y; Zingarelli, B | 1 |
| Ben-Ari, Y; Benjelloun, N; Charriaut-Marlangue, C; Ducrocq, S; Plotkine, M | 1 |
| Abdulmalek, K; Albertini, M; Caniatti, M; Clement, MG; Hussain, SN; Lafortuna, CL; Magder, S | 1 |
| Churchill, T; Jewell, LD; Jijon, HB; Madsen, KL; Malfair, D; Parsons, HG; Wessler, A | 1 |
| Al-Affar, EB; Liaudet, L; Szabó, C; Yang, Z | 1 |
| Aoyama, K; Chen, Y; Garnier, P; Gum, E; Liu, J; Matsumori, Y; Suh, SW; Swanson, RA | 1 |
| Besson, VC; Marchand-Verrecchia, C; Margaill, I; Plotkine, M | 1 |
| Burke, AS; Cox, RA; Enkhbaatar, P; Hawkins, HK; Komjáti, K; Mabley, JG; Murakami, K; Pacher, P; Salzman, AL; Schmalstieg, FC; Shimoda, K; Szabó, C; Traber, DL; Traber, LD; Zsengellér, Z | 1 |
| Bani, D; Ciampa, A; Cuzzocrea, S; Masini, E; Mazzocca, C; Suzuki, H; Suzuki, Y | 1 |
| Aksöyek, S; Avlan, D; Cinel, I; Cinel, L; Nayci, A; Oztürk, C; Taşkinlar, H; Unlü, A | 1 |
| Barnes, AD; Chen, M; Farivar, AS; Jagtap, P; MacKinnon-Patterson, BC; McCourtie, AS; Mulligan, MS; Salerno, CT; Szabó, C; Woolley, SM | 1 |
| Berger, I; Gero, D; Karck, M; Radovits, T; Seres, L; Szabó, C; Szabó, G | 1 |
| Areti, A; Gogoi, R; Komirishetty, P; Kumar, A; Ruby, PK; Sharma, SS; Sistla, R; Yerra, VG | 1 |
17 other study(ies) available for 3-aminobenzamide and 3-nitrotyrosine
| Article | Year |
|---|---|
Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase.
Topics: Adenosine Triphosphate; Animals; Benzamides; Cells, Cultured; Creatine Kinase; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Myocardium; Peroxidase; Poly(ADP-ribose) Polymerase Inhibitors; Rats; Rats, Wistar; Tyrosine | 1997 |
Role of peroxynitrite and poly (ADP-ribosyl) synthetase activation in cardiovascular derangement induced by zymosan in the rat.
Topics: Animals; Aortic Diseases; Benzamides; Enzyme Activation; Enzyme Inhibitors; Immunohistochemistry; Injections, Intraperitoneal; Male; Niacinamide; Nitrates; Oxidants; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Shock, Cardiogenic; Tyrosine; Zymosan | 1998 |
Peroxynitrite-induced thymocyte apoptosis: the role of caspases and poly (ADP-ribose) synthetase (PARS) activation.
Topics: Animals; Apoptosis; Benzamides; Caspase 1; Caspase 3; Caspases; Cell Death; Cells, Cultured; Cysteine Endopeptidases; DNA Fragmentation; Enzyme Activation; Enzyme Inhibitors; Flow Cytometry; Hydrogen Peroxide; Immunohistochemistry; Mice; Nitrates; Nitric Oxide; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Thymus Gland; Tyrosine | 1998 |
Protective effects of poly (ADP-ribose) synthase inhibitors in zymosan-activated plasma induced paw edema.
Topics: Animals; Benzamides; Complement Activation; Dose-Response Relationship, Drug; Edema; Enzyme Inhibitors; Free Radicals; Immunohistochemistry; Inflammation; Male; Niacinamide; Nitrates; Peroxidase; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats; Rats, Wistar; Tyrosine; Zymosan | 1999 |
Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, against laryngeal injury in rats.
Topics: Animals; Benzamides; Enzyme Inhibitors; Immunohistochemistry; Intubation, Intratracheal; Laryngeal Mucosa; Larynx; Male; Neutrophils; Peroxidase; Poly(ADP-ribose) Polymerase Inhibitors; Rats; Rats, Wistar; Tyrosine; Wounds and Injuries | 1999 |
Poly(ADP-ribose) synthase inhibition reduces ischemic injury and inflammation in neonatal rat brain.
Topics: Animals; Animals, Newborn; Benzamides; Brain Ischemia; Cell Death; Cerebral Infarction; Encephalitis; Female; Male; Motor Activity; Neurologic Examination; Neuroprotective Agents; Neutrophils; Nitrates; Poly(ADP-ribose) Polymerase Inhibitors; Polymers; Rats; Rats, Wistar; Reperfusion Injury; Signal Transduction; Stroke; Time Factors; Tyrosine | 2000 |
Role of poly-(ADP-ribose) synthetase in lipopolysaccharide-induced vascular failure and acute lung injury in pigs.
Topics: Animals; Benzamides; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Enzyme Inhibitors; Escherichia coli Infections; Female; Hemodynamics; Immunohistochemistry; Lipopolysaccharides; Male; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Proteins; Pulmonary Circulation; Respiratory Distress Syndrome; Respiratory Mechanics; Shock, Septic; Swine; Tyrosine | 2000 |
Inhibition of poly(ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis.
Topics: Animals; Benzamides; Chronic Disease; Colitis; Disease Models, Animal; Energy Metabolism; Enzyme Inhibitors; Inflammatory Bowel Diseases; Interferon-gamma; Interleukin-10; Intestinal Absorption; Intestinal Mucosa; Mice; Mice, Inbred Strains; Mice, Knockout; Neutrophils; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Proteins; Tumor Necrosis Factor-alpha; Tyrosine | 2000 |
Myocardial ischemic preconditioning in rodents is dependent on poly (ADP-ribose) synthetase.
Topics: Animals; Benzamides; Enzyme Inhibitors; Immunohistochemistry; Interleukin-10; Interleukin-12; Ischemic Preconditioning, Myocardial; Male; Mice; Mice, Knockout; Myocardial Reperfusion Injury; Myocardium; NAD; Peroxidase; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats; Rats, Wistar; Tissue Extracts; Tumor Necrosis Factor-alpha; Tyrosine | 2001 |
Hypoglycemic neuronal death and cognitive impairment are prevented by poly(ADP-ribose) polymerase inhibitors administered after hypoglycemia.
Topics: Animals; Astrocytes; Behavior, Animal; Benzamides; Benzopyrans; Cell Death; Cells, Cultured; Cognition Disorders; Disease Models, Animal; Drug Administration Schedule; Enzyme Inhibitors; Hypoglycemia; Isoquinolines; Male; Maze Learning; Mice; Mice, Knockout; Neurons; Poly(ADP-ribose) Polymerase Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Time Factors; Treatment Outcome; Tyrosine | 2003 |
Deleterious activation of poly(ADP-ribose)polymerase-1 in brain after in vivo oxidative stress.
Topics: Animals; Apoptosis; Benzamides; Brain; Brain Diseases; Enzyme Activation; Immunohistochemistry; Male; Malonates; Oxidative Stress; Poly Adenosine Diphosphate Ribose; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tyrosine | 2003 |
Inhibition of poly (ADP-ribose) polymerase attenuates acute lung injury in an ovine model of sepsis.
Topics: Animals; Antithrombins; DNA Damage; Enzyme Inhibitors; Female; Hematocrit; Hemoglobins; Immunohistochemistry; Indoles; Lipid Peroxidation; Lung; Malondialdehyde; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Poly(ADP-ribose) Polymerase Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sepsis; Sheep; Time Factors; Tyrosine | 2004 |
Inhibition of poly(ADP-ribose) polymerase prevents allergen-induced asthma-like reaction in sensitized Guinea pigs.
Topics: Allergens; Animals; Anti-Asthmatic Agents; Asthma; Benzamides; Bronchoalveolar Lavage Fluid; Enzyme Inhibitors; Guinea Pigs; Immunohistochemistry; Isoquinolines; Lung; Male; Malondialdehyde; Mast Cells; Nitric Oxide; Ovalbumin; Peroxidase; Poly(ADP-ribose) Polymerase Inhibitors; Respiratory Mechanics; Tumor Necrosis Factor-alpha; Tyrosine | 2004 |
The role of poly(ADP-ribose) synthetase inhibition on the intestinal mucosal barrier after thermal injury.
Topics: Animals; Bacterial Translocation; Benzamides; Burns; Enzyme Inhibitors; Intestinal Mucosa; Intestine, Small; Liver; Lymph Nodes; Malondialdehyde; Mesentery; Poly(ADP-ribose) Polymerase Inhibitors; Random Allocation; Rats; Rats, Wistar; Spleen; Tyrosine | 2004 |
Poly (ADP) ribose polymerase inhibition improves rat cardiac allograft survival.
Topics: Animals; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Graft Survival; Heart Transplantation; Indoles; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats; Rats, Inbred Lew; Tyrosine | 2005 |
Single dose treatment with PARP-inhibitor INO-1001 improves aging-associated cardiac and vascular dysfunction.
Topics: Acetylcholine; Aging; Animals; Enzyme Inhibitors; Heart; Immunohistochemistry; Indoles; Models, Animal; Myocardium; Phenylephrine; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats; Tyrosine | 2007 |
PARP inhibition attenuates neuroinflammation and oxidative stress in chronic constriction injury induced peripheral neuropathy.
Topics: Animals; Benzamides; Constriction, Pathologic; Cyclooxygenase 2; Hyperalgesia; Inflammation; Male; NAD; Neuritis; Neuroprotective Agents; Oxidative Stress; Pain Measurement; Peripheral Nervous System Diseases; Poly(ADP-ribose) Polymerase Inhibitors; Rats; Rats, Sprague-Dawley; Sensation; Tyrosine; Walking | 2016 |